Ph Homeostasis in Lactic Acid Bacteria

Total Page:16

File Type:pdf, Size:1020Kb

Load more

University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Faculty Publications in Food Science and Technology Food Science and Technology Department September 1993 pH Homeostasis in Lactic Acid Bacteria Robert W. Hutkins University of Nebraska-Lincoln, [email protected] Nancy L. Nannen University of Nebraska-Lincoln Follow this and additional works at: https://digitalcommons.unl.edu/foodsciefacpub Part of the Food Science Commons Hutkins, Robert W. and Nannen, Nancy L., "pH Homeostasis in Lactic Acid Bacteria" (1993). Faculty Publications in Food Science and Technology. 28. https://digitalcommons.unl.edu/foodsciefacpub/28 This Article is brought to you for free and open access by the Food Science and Technology Department at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Faculty Publications in Food Science and Technology by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. pH Homeostasis in Lactlc Acld Bacterial ROBERT W. HUTKINS and NANCY L. NANNEN Department of Food Science and Technology University of Nebraska-Lincoln Lincoln 68583.0919 ABSTRACT especially important concern for lactic acid The ability of lactic acid bacteria to bacteria used as dairy starter cultures because regulate their cytoplasmic or intracellular these obligate acid-producers must cope with pH is one of the most important physio- low pH, high acid environments during ordi- logical requirements of the cells. Cells nary growth in milk. This paper reviews the unable to maintain a near neutral in- effects of low pH, and in particular, low in- tracellular pH during growth or storage tracellular pH (pHin), on growth and metabo- at low extracellular pH may lose viabil- lism of lactic acid bacteria and discusses how ity and cellular activity. Despite the im- cytoplasmic pH regulates cell metabolism and portance of pH homeostasis in the lactic how cytoplasmic pH is regulated in the lactic acid bacteria, however, an understanding acid bacteria. of cytoplasmic pH regulation has only recently begun to emerge. This review GROWTH OF LACTIC ACID describes the specific effects of low pH BACTERIA IN MILK on lactic acid bacteria, reports recent re- In general, growth of lactic acid bacteria search on the physiological role of in- continues as long as 1) carbohydrates, amino tracellular pH as a regulator of various acids, and other nutrients are available; 2) metabolic activities in lactic acid bacte- toxic or inhibiting compounds, such as hydro- ria, and presents the means by which gen peroxide, are removed, degraded, or lactic acid bacteria defend against low diluted; or 3) the hydrogen ion concentration is intracellular pH. Particular attention is maintained above the level that a specific devoted to the proton-translocating strain can tolerate. For example, growth of ATPase, an enzyme that is largely Lactococcus lactis ssp. lactis, Lactococcus lac- responsible for pH homeostasis in fer- tis ssp. cremoris, and Streptococcus ther- mentative lactic acid bacteria. mophilus in milk occurs until the pH reaches (Key words: pH, pH homeostasis, lactic approximately 4.5, despite nonlimiting concen- acid bacteria) trations of nutrients and the relative absence of inhibitory compounds (21, 61. 98). Low pH Abbreviation key: pHout = extracellular pH, (or high lactic acid) is frequently growth- pHi, = intracellular pH, ApH = pH gradient, limiting for lactic acid bacteria that are grown H+-ATPase = proton-translocating ATPase. in milk or in weakly buffered bacteriological media (12, 61). INTRODUCTION Although lactic acid bacteria may fre- quently be isolated from acid habitats (69), The means by which microorganisms toler- such sour and are commonly thought ate variations of environmental pH been an as milk, has to favor low pH environments, except for cer- active area of investigation [for reviews, see tain Lactobacillus species, lactic acid bacteria (16, 41, 46, 51, 76)]. pH homeostasis is an are probably best characterized as neutrophiles. For example, optimal growth rates for the mesophilic dairy starter cultures, L. lactis ssp. Received February 10, 1992. kactis and L. lactis ssp. cremoris have been Accepted April 28, 1992. reported to occur within an external or ex- Published as Paper Number 9795, Journal Series Nebraska Agricultural Experiment Station, Lincoln tracellular pH (pHout) range of 6.3 to 6.9 (12, 685834919, 13,37). The optimal pHout for the thermophilic 1993 J Dairy Sci 76:2354-2365 2354 SYMPOSIUM: DAIRY STARTER CULTURES 2355 lactic acid bacterium S. themphilus was be- ied the damage to L.. fuctis ssp. fuctis ML3 tween 6.5 and 7.5 (9, 72). Among the lactic resulting from growth at low pH. Maximum acid bacteria used as dairy starters, only the specific growth rates occurred at pHout 6.3. lactobacilli (Lactobacillus helveticus and Lac- Cell damage, determined as the ratio of the tobacillus delbrueckii ssp. bulgaricus) appear transient growth rate to the normal growth rate, to grow optimally at acid pH; maximal growth began to occur at medium pH or pbut5.0, and occurs at pH 5.5 to 5.8 (9, 95). the specific growth rate approached zero at Not only do most lactic acid bacteria grow pHout 4.0. A reduction in the specific activity more slowly at low pH, but acid damage and of the enzymes hexokinase and acetate kinase, loss of cell viability may also occur in cells as well as the overall glycolytic activity, also held at low pH. In fermented dairy products, occurred at pH 4.0. Although pHin was not such as yogurt or cultured buttermilk, whether measured, Harvey (37) suggested that the cells the lactic acid bacteria are viable or injured by were able to maintain constant pHh as long as the lactic acid and low pH environment, once pbutwas >5.0. Many other workers (18, 55, the desired pH is reached frequently is techno- 72, 98) have reported that growth of lactic logically irrelevant. Moreover, inhibition of the streptococci and lactococci decreases sharply starter culture by lactic acid and low pH acts to when the medium pH reaches 5.0. Similarly, prevent, in part, overacidification of the fin- pH-induced damage also occurred in the fecal ished product. In the production of yogurt, for coccus, Enterococcus fuecaZis (formerly Strep- example, fermentation lowers the pH of the tococcus faeculis). Below pH 5.0, derangement milk from 6.5 to between 4.0 and 4.5, and the of membrane structures and solute leakage oc- milk coagulates. Unrestricted growth and fer- curred (60). Although the changes were revers- mentation in yogurt (or postacidification) by ible in both L Zuctis ssp. lactis and E. faeculis, the lactic culture may result in excessive acid a lag in fresh media occurred following ex- and flavor defects. In other cases, however, posure to these low pH (37, 60). maintenance of culture viability under acid Bender et al. (1 1) studied the effect of gross conditions is desired and necessary. Cultures membrane damage caused by acidification in and culture adjuncts (e.g., Lactobacillus various oral streptococci. Damage was as- acidophilus) that are added to yogurt for ther- sessed by measurement of the release of mag- apeutic value must remain viable during stor- nesium ions from cells that were incubated at age at low pH and, ultimately, must survive specific pH at room temperature. Magnesium the acid stomach environment. Mixed genus, was not lost from Streptococcus mutuns, Strep- thermophilic cultures used for Italian cheese tococcus sanguis, and Streptococcus salivarius manufacture (i.e., S. themphilus and Lb. hel- at pH near neutrality, but magnesium efflux veticus) are usually propagated or cultivated occurred after the pH was lowered to <4.0. At together; that the former is more acid-sensitive pH 2 or 3, release of magnesium was rapid and than the latter may result in variable strain extensive. In contrast, Lactobacillus casei ratios. In the industrial production of starter leaked magnesium only at pH <3. Those wor- cultures, sensitivity to acid is undesirable be- kers (1 1) suggested that differences in the sus- cause high cell densities may not be achieved, ceptibility to gross membrane damage caused and cell viability may be impaired (77). by acidification appeared to vary among organ- isms and was correlated with the degree of acid tolerance. ACID DAMAGE DURING GROWTH AT LOW pH Conventionally prepared, milk-based (with- out added buffers) starter cultures are espe- The basic knowledge that starter cultures cially prone to acid damage because the final grow best at neutral or near neutral pH, that medium pH usually is <5.0. Such cultures, if acid environments are damaging to cells, that they are not used soon, behave poorly in fer- starters tend to lose activity during prolonged mented milks, resulting in slow or sluggish storage at low pH, and that ovempened or culture performance (39, 84). To minimize overacidified cultures perform slowly or result these acid-damaging effects in dairy starter in inferior productions has long been recog- cultures, the starter culture industry has nized (54, 55, 77, 84). Harvey (37) fmt stud- devoted considerable effort to development of Journal of Dahy Science Vol. 76. No. 8, 1993 2356 HUTKINS AND NANNEN TABLE 1. Optimal pH for intracellular enzymes from lactic acid bacteria. ~~~~~ PH Enzyme Organism Optimum Reference B-D-Galactosidase Streptococcus thcmphilus 7.1 8-D-Galactosidase S. themphilus 8.0 Phosphofructokinase Lactobacillus bulgaricus 8.2 6-D-Phosphogalactoside Lactococcus lactis galactohydrolase ssp. cremris 7.0 Acylglyccrol Lactococcus lactis ssp. lactis acylhydrolase (lipase) L lactis ssp. cremris 7.0-8.5 Pyruvate kinase L loctis ssp. lactis 6.9-7.5 D-Tagatose 1.6-diphosphate L kactis ssp. lactis aldolase L &tis ssp. cremris 7.0-7.3 Glucose-6-phosphate dehydrogenase Lactobacillus casei 6.8 6-Phosphogluconate de hydrogenase Lb. casei 6.8 Aminopeptidase L lactis ssp. cremoris 7 .O Intracellular proteinase L lactis ssp. lactis 7.5 Aminopeptidase Lb.
Recommended publications
  • Current Trends of Enterococci in Dairy Products: a Comprehensive Review of Their Multiple Roles

    Current Trends of Enterococci in Dairy Products: a Comprehensive Review of Their Multiple Roles

    foods Review Current Trends of Enterococci in Dairy Products: A Comprehensive Review of Their Multiple Roles Maria de Lurdes Enes Dapkevicius 1,2,* , Bruna Sgardioli 1,2 , Sandra P. A. Câmara 1,2, Patrícia Poeta 3,4 and Francisco Xavier Malcata 5,6,* 1 Faculty of Agricultural and Environmental Sciences, University of the Azores, 9700-042 Angra do Heroísmo, Portugal; [email protected] (B.S.); [email protected] (S.P.A.C.) 2 Institute of Agricultural and Environmental Research and Technology (IITAA), University of the Azores, 9700-042 Angra do Heroísmo, Portugal 3 Microbiology and Antibiotic Resistance Team (MicroART), Department of Veterinary Sciences, University of Trás-os-Montes and Alto Douro (UTAD), 5001-801 Vila Real, Portugal; [email protected] 4 Associated Laboratory for Green Chemistry (LAQV-REQUIMTE), University NOVA of Lisboa, 2829-516 Lisboa, Portugal 5 LEPABE—Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, 420-465 Porto, Portugal 6 FEUP—Faculty of Engineering, University of Porto, 4200-465 Porto, Portugal * Correspondence: [email protected] (M.d.L.E.D.); [email protected] (F.X.M.) Abstract: As a genus that has evolved for resistance against adverse environmental factors and that readily exchanges genetic elements, enterococci are well adapted to the cheese environment and may reach high numbers in artisanal cheeses. Their metabolites impact cheese flavor, texture, Citation: Dapkevicius, M.d.L.E.; and rheological properties, thus contributing to the development of its typical sensorial properties. Sgardioli, B.; Câmara, S.P.A.; Poeta, P.; Due to their antimicrobial activity, enterococci modulate the cheese microbiota, stimulate autoly- Malcata, F.X.
  • Oral Administration of Lactobacillus Gasseri SBT2055 Is Effective In

    Oral Administration of Lactobacillus Gasseri SBT2055 Is Effective In

    www.nature.com/scientificreports OPEN Oral administration of Lactobacillus gasseri SBT2055 is effective in preventing Porphyromonas Received: 23 June 2015 Accepted: 7 March 2017 gingivalis-accelerated periodontal Published: xx xx xxxx disease R. Kobayashi1, T. Kobayashi2, F. Sakai3, T. Hosoya3, M. Yamamoto1 & T. Kurita-Ochiai1 Probiotics have been used to treat gastrointestinal disorders. However, the effect of orally intubated probiotics on oral disease remains unclear. We assessed the potential of oral administration of Lactobacillus gasseri SBT2055 (LG2055) for Porphyromonas gingivalis infection. LG2055 treatment significantly reduced alveolar bone loss, detachment and disorganization of the periodontal ligament, and bacterial colonization by subsequent P. gingivalis challenge. Furthermore, the expression and secretion of TNF-α and IL-6 in gingival tissue was significantly decreased in LG2055-administered mice after bacterial infection. Conversely, mouse β-defensin-14 (mBD-14) mRNA and its peptide products were significantly increased in distant mucosal components as well as the intestinal tract to which LG2055 was introduced. Moreover, IL-1β and TNF-α production from THP-1 monocytes stimulated with P. gingivalis antigen was significantly reduced by the addition of humanβ -defensin-3. These results suggest that gastrically administered LG2055 can enhance immunoregulation followed by periodontitis prevention in oral mucosa via the gut immune system; i.e., the possibility of homing in innate immunity. Porphyromonas gingivalis, a Gram-negative anaerobe, is one of the major pathogens associated with chronic periodontitis, a disease that causes the destruction of alveolar bone, and, as a consequence, tooth loss1. Recent evidence suggests that this bacterium contributes to periodontitis by functioning as a keystone pathogen2, 3.
  • Bacteriocin‐Like Inhibitory Activities of Seven Lactobacillus Delbrueckii

    Bacteriocin‐Like Inhibitory Activities of Seven Lactobacillus Delbrueckii

    Letters in Applied Microbiology ISSN 0266-8254 ORIGINAL ARTICLE Bacteriocin-like inhibitory activities of seven Lactobacillus delbrueckii subsp. bulgaricus strains against antibiotic susceptible and resistant Helicobacter pylori strains L. Boyanova, G. Gergova, R. Markovska, D. Yordanov and I. Mitov Department of Medical Microbiology, Medical University of Sofia, Sofia, Bulgaria Significance and Impact of the Study: In this study, anti-Helicobacter pylori activity of seven Lactobacil- lus delbrueckii subsp. bulgaricus (GLB) strains was evaluated by four cell-free supernatant (CFS) types. The GLB strains produced heat-stable bacteriocin-like inhibitory substances (BLISs) with a strong anti-H. pylori activity and some neutralized, catalase- and heat-treated CFSs inhibited >83% of the test strains. Bacteriocin-like inhibitory substance production of GLB strains can render them valuable probiotics in the control of H. pylori infection. Keywords Abstract antibiotics, bacteriocins, Helicobacter, Lactobacillus, probiotics. The aim of the study was to detect anti-Helicobacter pylori activity of seven Lactobacillus delbrueckii subsp. bulgaricus (GLB) strains by four cell-free Correspondence supernatant (CFS) types. Activity of non-neutralized and non-heat-treated Lyudmila Boyanova, Department of Medical (CFSs1), non-neutralized and heat-treated (CFSs2), pH neutralized, catalase- Microbiology, Medical University of Sofia, treated and non-heat-treated (CFSs3), or neutralized, catalase- and heat-treated Zdrave Street 2, 1431 Sofia, Bulgaria. (CFSs4) CFSs against 18 H. pylori strains (11 of which with antibiotic E-mail: [email protected] resistance) was evaluated. All GLB strains produced bacteriocin-like inhibitory 2017/1069: received 3 June 2017, revised 27 substances (BLISs), the neutralized CFSs of two GLB strains inhibited >81% of August 2017 and accepted 25 September test strains and those of four GLB strains were active against >71% of 2017 antibiotic resistant strains.
  • Characterization of a Lactobacillus Brevis Strain with Potential Oral Probiotic Properties Fang Fang1,2* , Jie Xu1,2, Qiaoyu Li1,2, Xiaoxuan Xia1,2 and Guocheng Du1,3

    Characterization of a Lactobacillus Brevis Strain with Potential Oral Probiotic Properties Fang Fang1,2* , Jie Xu1,2, Qiaoyu Li1,2, Xiaoxuan Xia1,2 and Guocheng Du1,3

    Fang et al. BMC Microbiology (2018) 18:221 https://doi.org/10.1186/s12866-018-1369-3 RESEARCHARTICLE Open Access Characterization of a Lactobacillus brevis strain with potential oral probiotic properties Fang Fang1,2* , Jie Xu1,2, Qiaoyu Li1,2, Xiaoxuan Xia1,2 and Guocheng Du1,3 Abstract Background: The microflora composition of the oral cavity affects oral health. Some strains of commensal bacteria confer probiotic benefits to the host. Lactobacillus is one of the main probiotic genera that has been used to treat oral infections. The objective of this study was to select lactobacilli with a spectrum of probiotic properties and investigate their potential roles in oral health. Results: An oral isolate characterized as Lactobacillus brevis BBE-Y52 exhibited antimicrobial activities against Streptococcus mutans, a bacterial species that causes dental caries and tooth decay, and secreted antimicrobial compounds such as hydrogen peroxide and lactic acid. Compared to other bacteria, L. brevis BBE-Y52 was a weak acid producer. Further studies showed that this strain had the capacity to adhere to oral epithelial cells. Co- incubation of L. brevis BBE-Y52 with S. mutans ATCC 25175 increased the IL-10-to-IL-12p70 ratio in peripheral blood mononuclear cells, which indicated that L. brevis BBE-Y52 could alleviate inflammation and might confer benefits to host health by modulating the immune system. Conclusions: L. brevis BBE-Y52 exhibited a spectrum of probiotic properties, which may facilitate its applications in oral care products. Keywords: Lactobacillus brevis, Antimicrobial activity, Hydrogen peroxide, Adhesion, Immunomodulation Background properties may prevent the colonization of oral patho- Oral infectious diseases, such as dental caries and peri- gens through different mechanisms.
  • Oral Ecologixtm Oral Health & Microbiome Profile Phylo Bioscience Laboratory

    Oral Ecologixtm Oral Health & Microbiome Profile Phylo Bioscience Laboratory

    Oral EcologiXTM Oral Health & Microbiome Profile Phylo Bioscience Laboratory INTERPRETIVE GUIDE DISCLAIMER: THIS INFORMATION IS PROVIDED FOR THE USE OF PHYSICIANS AND OTHER LICENSED HEALTH CARE PRACTITIONERS ONLY. THIS INFORMATION IS NOT FOR USE BY CONSUMERS. THE INFORMATION AND OR PRODUCTS ARE NOT INTENDED FOR USE BY CONSUMERS OR PHYSICIANS AS A MEANS TO CURE, TREAT, PREVENT, DIAGNOSE OR MITIGATE ANY DISEASE OR OTHER MEDICAL CONDITION. THE INFORMATION CONTAINED IN THIS DOCUMENT IS IN NO WAY TO BE TAKEN AS PRESCRIPTIVE NOR TO REPLACE THE PHYSICIANS DUTY OF CARE AND PERSONALISED CARE PRACTICES. INTERPRETIVE GUIDE Oral EcologiX™ INTRODUCTION Due to recent advancements in culture-independent techniques, it is now possible to measure the composition of the human microbiota. The oral cavity is a complex ecosystem, comprising several habitats including the teeth, gums, tongue and tonsils, all colonised by bacteria1. The oral microbiota is comprised of approximately 600 taxa at the species level, with different groups and subsets inhabiting different niches. The microbiota of the oral cavity exists as a complex biofilm that remains stable despite environmental changes. However, dysbiosis, in form of infection, injury, dietary changes and risk-associated factors (e.g. smoking) may disrupt the biofilm community, favouring colonisation and invasion of pathogens. Disruption of the biofilm community to a pathogenic profile, induces host immune responses, chronic inflammation and ultimately development of local and systemic diseases. However, much of this damage is reversible if pathogenic communities are removed, and homeostasis is restored. To this end, Phylobioscience have developed the Oral EcologiXTM oral health and microbiome profile, a ground breaking tool for analysis of oral microbiota composition and host immune responses.
  • The Role of the Microbiome in Oral Squamous Cell Carcinoma with Insight Into the Microbiome–Treatment Axis

    The Role of the Microbiome in Oral Squamous Cell Carcinoma with Insight Into the Microbiome–Treatment Axis

    International Journal of Molecular Sciences Review The Role of the Microbiome in Oral Squamous Cell Carcinoma with Insight into the Microbiome–Treatment Axis Amel Sami 1,2, Imad Elimairi 2,* , Catherine Stanton 1,3, R. Paul Ross 1 and C. Anthony Ryan 4 1 APC Microbiome Ireland, School of Microbiology, University College Cork, Cork T12 YN60, Ireland; [email protected] (A.S.); [email protected] (C.S.); [email protected] (R.P.R.) 2 Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, National Ribat University, Nile Street, Khartoum 1111, Sudan 3 Teagasc Food Research Centre, Moorepark, Fermoy, Cork P61 C996, Ireland 4 Department of Paediatrics and Child Health, University College Cork, Cork T12 DFK4, Ireland; [email protected] * Correspondence: [email protected] Received: 30 August 2020; Accepted: 12 October 2020; Published: 29 October 2020 Abstract: Oral squamous cell carcinoma (OSCC) is one of the leading presentations of head and neck cancer (HNC). The first part of this review will describe the highlights of the oral microbiome in health and normal development while demonstrating how both the oral and gut microbiome can map OSCC development, progression, treatment and the potential side effects associated with its management. We then scope the dynamics of the various microorganisms of the oral cavity, including bacteria, mycoplasma, fungi, archaea and viruses, and describe the characteristic roles they may play in OSCC development. We also highlight how the human immunodeficiency viruses (HIV) may impinge on the host microbiome and increase the burden of oral premalignant lesions and OSCC in patients with HIV. Finally, we summarise current insights into the microbiome–treatment axis pertaining to OSCC, and show how the microbiome is affected by radiotherapy, chemotherapy, immunotherapy and also how these therapies are affected by the state of the microbiome, potentially determining the success or failure of some of these treatments.
  • Lactic Acid Bacteria

    Lactic Acid Bacteria

    robioti f P cs o & l a H n e r a u l t o h J Wedajo, J Prob Health 2015, 3:2 Journal of Probiotics & Health DOI: 10.4172/2329-8901.1000129 ISSN: 2329-8901 Review Article Open Access Lactic Acid Bacteria: Benefits, Selection Criteria and Probiotic Potential in Fermented Food Bikila Wedajo* Department of biology, Arba Minch University, Ethiopia *Corresponding author: Bikila Wedajo, Department of biology, Arba Minch University, Ethiopia, Tel: +251-46-881077; E-mail: [email protected] Rec date: Jul 07, 2015, Acc date: Aug 03, 2015, Pub date: Aug 07, 2015 Copyright: © 2015 Bikila W. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Probiotics have been defined a number of times. Presently the most common definition is that from the FAO/WHO which states that probiotics are “live microorganisms that, administered in adequate amounts, confer a health benefit on the host.” One of the most significant groups of probiotic organisms are the lactic acid bacteria, commonly used in fermented dairy products. There is an increase in interest in these species as research is beginning to reveal the many possible health benefits associated with lactic acid bacteria. The difficulty in identifying and classifying strains has complicated research, since benefits may only be relevant to particular strains. Nevertheless, lactic acid bacteria have a number of well-established and potential benefits. They can improve lactose digestion, play a role in preventing and treating diarrhea and act on the immune system, helping the body to resist and fight infection.
  • Isolation of Lactic-Acid Related Bacteria from the Pig Mucosal P

    Isolation of Lactic-Acid Related Bacteria from the Pig Mucosal P

    Aus dem Institut für Tierernährung des Fachbereichs Veterinärmedizin der Freien Universität Berlin Isolation of lactic acid-related bacteria from the pig mucosal proximal gastrointestinal tract, including Olsenella umbonata sp. nov. and Veillonella magna sp. nov. Inaugural-Dissertation zur Erlangung des Grades eines Doktors der Veterinärmedizin an der Freien Universität Berlin vorgelegt von Mareike Kraatz Tierärztin aus Berlin Berlin 2011 Journal-Nr.: 3431 Gedruckt mit Genehmigung des Fachbereichs Veterinärmedizin der Freien Universität Berlin Dekan: Univ.-Prof. Dr. Leo Brunnberg Erster Gutachter: Univ.-Prof. a. D. Dr. Ortwin Simon Zweiter Gutachter: Univ.-Prof. Dr. Lothar H. Wieler Dritter Gutachter: Univ.-Prof. em. Dr. Dr. h. c. Gerhard Reuter Deskriptoren (nach CAB-Thesaurus): anaerobes; Bacteria; catalase; culture media; digestive tract; digestive tract mucosa; food chains; hydrogen peroxide; intestinal microorganisms; isolation; isolation techniques; jejunum; lactic acid; lactic acid bacteria; Lactobacillus; Lactobacillus plantarum subsp. plantarum; microbial ecology; microbial flora; mucins; mucosa; mucus; new species; Olsenella; Olsenella profusa; Olsenella uli; oxygen; pigs; propionic acid; propionic acid bacteria; species composition; stomach; symbiosis; taxonomy; Veillonella; Veillonella ratti Tag der Promotion: 21. Januar 2011 Diese Dissertation ist als Buch (ISBN 978-3-8325-2789-1) über den Buchhandel oder online beim Logos Verlag Berlin (http://www.logos-verlag.de) erhältlich. This thesis is available as a book (ISBN 978-3-8325-2789-1)
  • Use of Lactic Acid Bacteria for Decreasing Gum

    Use of Lactic Acid Bacteria for Decreasing Gum

    (19) & (11) EP 2 229 949 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: A61K 35/74 (2006.01) C12N 1/20 (2006.01) 21.12.2011 Bulletin 2011/51 C12Q 1/04 (2006.01) A61K 8/99 (2006.01) A61K 9/00 (2006.01) A61P 1/02 (2006.01) (21) Application number: 10168703.6 (22) Date of filing: 14.06.2005 (54) USE OF LACTIC ACID BACTERIA FOR DECREASING GUM BLEEDING AND REDUCING ORAL INFLAMMATION VERWENDUNG VON MILCHSÄUREBAKTERIEN ZUR VERRINGERUNG VON ZAHNFLEISCHBLUTEN UND MUNDENTZÜNDUNG UTILISATION DE BACTERIES D’ACIDE LACTIQUE POUR REDUIRE LE SAIGNEMENT DES GENCIVES ET L’INFLAMMATION ORALE (84) Designated Contracting States: (56) References cited: AT BE BG CH CY CZ DE DK EE ES FI FR GB GR EP-A1- 1 312 667 EP-A1- 1 498 039 HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR WO-A2-99/47657 US-A- 3 992 519 US-A1- 2003 077 814 US-A1- 2004 146 493 (30) Priority: 14.06.2004 US 580279 P 08.06.2005 US 147880 • VALEUR N ET AL: "Colonization and Immunomodulation by Lactobacillus Reuteri (43) Date of publication of application: ATCC 55730 in the Human Gastrointestinal Tract" 22.09.2010 Bulletin 2010/38 APPLIED AND ENVIRONMENTAL MICROBIOLOGY, AMERICAN SOCIETY FOR (62) Document number(s) of the earlier application(s) in MICROBIOLOGY, US LNKD- DOI:10.1128/AEM. accordance with Art. 76 EPC: 70.2.1176-1181.2004, vol. 70, no. 2, 1 February 05752662.6 / 1 765 282 2004 (2004-02-01), pages 1176-1181, XP002992069 ISSN: 0099-2240 (73) Proprietor: Biogaia AB • "BioGaia’sHealthy bacterium reduces the risk for
  • C. Difficile: Trials, Treatments and New Guidelines

    C. Difficile: Trials, Treatments and New Guidelines

    C. difficile: trials, treatments and new guidelines CONTENTS REVIEW: Vulnerability of long-term care facility residents to Clostridium difficile infection due to microbiome disruptions FUTURE MICROBIOLOGY Vol. 13, No. 13 INTERVIEW: The gut microbiome and the potentials of probiotics: an interview with Simon Gaisford FUTURE MICROBIOLOGY Vol. 14, No. 4 REVIEW: Clostridioides (Clostridium) difficile infection: current and alternative therapeutic strategies FUTURE MICROBIOLOGY Vol. 13, No. 4 EDITORIAL: Microbiome therapeutics – the pipeline for C. difficile infection INTERVIEW: Updates on C. difficile: from clinical trials and guidelines – an interview with Yoav Golan NEWS ARTICLE: Could common painkillers promote C. difficile infection? Review For reprint orders, please contact: [email protected] Vulnerability of long-term care facility residents to Clostridium difficile infection due to microbiome disruptions Beth Burgwyn Fuchs*,1, Nagendran Tharmalingam1 & Eleftherios Mylonakis**,1 1Rhode Island Hospital, Alpert Medical School & Brown University, Providence, Rhode Island 02903 *Author for correspondence: Tel.: +401 444 7309; Fax: +401 606 5624; Helen [email protected]; **Author for correspondence: Tel.: +401 444 7845; Fax: +401 444 8179; [email protected] Aging presents a significant risk factor for Clostridium difficile infection (CDI). A disproportionate number of CDIs affect individuals in long-term care facilities compared with the general population, likely due to the vulnerable nature of the residents and shared environment. Review of the literature cites a number of underlying medical conditions such as the use of antibiotics, proton pump inhibitors, chemotherapy, renal disease and feeding tubes as risk factors. These conditions alter the intestinal environment through direct bacterial killing, changes to pH that influence bacterial stabilities or growth, or influence nutrient availability that direct population profiles.
  • In Vitro Evaluation of Antimicrobial Activity of Lactic Acid Bacteria Against Clostridium Difficile

    In Vitro Evaluation of Antimicrobial Activity of Lactic Acid Bacteria Against Clostridium Difficile

    Toxicol. Res. Vol. 29, No. 2, pp. 99-106 (2013) Open Access http://dx.doi.org/10.5487/TR.2013.29.2.099 plSSN: 1976-8257 eISSN: 2234-2753 In Vitro Evaluation of Antimicrobial Activity of Lactic Acid Bacteria against Clostridium difficile Joong-Su Lee, Myung-Jun Chung and Jae-Gu Seo R&D Center, CellBiotech, Co. Ltd., Gyunggi, Korea (Received June 7, 2013; Revised June 12, 2013; Accepted June 12, 2013) Clostridium difficile infection (CDI) has become a significant threat to public health. Although broad-spec- trum antibiotic therapy is the primary treatment option for CDI, its use has evident limitations. Probiotics have been proved to be effective in the treatment of CDI and are a promising therapeutic option for CDI. In this study, 4 strains of lactic acid bacteria (LAB), namely, Lactobacillus rhamnosus (LR5), Lactococ- cuslactis (SL3), Bifidobacterium breve (BR3), and Bifidobacterium lactis (BL3) were evaluated for their anti-C. difficile activity. Co-culture incubation of C. difficile (106 and 1010 CFU/ml) with each strain of LAB indicated that SL3 possessed the highest antimicrobial activity over a 24-hr period. The cell-free supernatants of the 4 LAB strains exhibited MIC50 values between 0.424 mg/ml (SL3) and 1.318 (BR3) mg/ml. These results may provide a basis for alternative therapies for the treatment of C. difficile-associ- ated gut disorders. Key words: Clostridium difficile infection, lactic acid bacteria, antimicrobial activity, cell-free supernatant INTRODUCTION alternative therapies based on bacterial replacement is con- sidered important due to the rapid emergence of antibiotic- Clostridium difficile is an infectious Gram-positive spore resistant pathogenic strains and the adverse consequences of forming, toxin-producing bacterium and causes mild to antibiotic therapies on the protective microbiota (7).
  • Dual Inhibition of Salmonella Enterica and Clostridium Perfringens by New Probiotic Candidates Isolated from Chicken Intestinal Mucosa

    Dual Inhibition of Salmonella Enterica and Clostridium Perfringens by New Probiotic Candidates Isolated from Chicken Intestinal Mucosa

    microorganisms Article Dual Inhibition of Salmonella enterica and Clostridium perfringens by New Probiotic Candidates Isolated from Chicken Intestinal Mucosa Ayesha Lone 1,†, Walid Mottawea 1,2,† , Yasmina Ait Chait 1 and Riadh Hammami 1,* 1 NuGUT Research Platform, School of Nutrition Sciences, Faculty of Health Sciences, University of Ottawa, Ottawa, ON K1H8M5, Canada; [email protected] (A.L.); [email protected] (W.M.); [email protected] (Y.A.C.) 2 Department of Microbiology and Immunology, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt * Correspondence: [email protected]; Tel.: +1-613-562-5800 (ext. 4110) † Those authors Contributed equally to this work. Abstract: The poultry industry is the fastest-growing agricultural sector globally. With poultry meat being economical and in high demand, the end product’s safety is of importance. Globally, governments are coming together to ban the use of antibiotics as prophylaxis and for growth promotion in poultry. Salmonella and Clostridium perfringens are two leading pathogens that cause foodborne illnesses and are linked explicitly to poultry products. Furthermore, numerous outbreaks occur every year. A substitute for antibiotics is required by the industry to maintain the same productivity level and, hence, profits. We aimed to isolate and identify potential probiotic strains from the ceca mucosa of the chicken intestinal tract with bacteriocinogenic properties. We were able to isolate multiple and diverse strains, including a new uncultured bacterium, with inhibitory activity against Salmonella Typhimurium ATCC 14028, Salmonella Abony NCTC 6017, Salmonella Choleraesuis Citation: Lone, A.; Mottawea, W.; ATCC 10708, Clostridium perfringens ATCC 13124, and Escherichia coli ATCC 25922. The five most Ait Chait, Y.; Hammami, R.